GEU2000588Y - Medicinal Means Deprivazini - Google Patents

Medicinal Means Deprivazini

Info

Publication number
GEU2000588Y
GEU2000588Y GEAU1999000729U GEU2000588Y GE U2000588 Y GEU2000588 Y GE U2000588Y GE AU1999000729 U GEAU1999000729 U GE AU1999000729U GE U2000588 Y GEU2000588 Y GE U2000588Y
Authority
GE
Georgia
Prior art keywords
deprivazini
medicinal means
medicinal
anesthesin
talc
Prior art date
Application number
Inventor
Elena Kereselidze-Giorgobiani
Tinatin Giorgobiani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to GEAU1999000729 priority Critical patent/GEU2000588Y/en
Publication of GEU2000588Y publication Critical patent/GEU2000588Y/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Technical Result Increase in treatment efficiency. 2. Essence A medicinal means contains zinc oxide, anesthesin, starch, talc and non-aqueous lanolin. 3. Field of Application Medicine, therapy.
GEAU1999000729 1999-06-15 1999-06-15 Medicinal Means Deprivazini GEU2000588Y (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GEAU1999000729 GEU2000588Y (en) 1999-06-15 1999-06-15 Medicinal Means Deprivazini

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GEAU1999000729 GEU2000588Y (en) 1999-06-15 1999-06-15 Medicinal Means Deprivazini

Publications (1)

Publication Number Publication Date
GEU2000588Y true GEU2000588Y (en) 2000-02-10

Family

ID=45468584

Family Applications (1)

Application Number Title Priority Date Filing Date
GEAU1999000729 GEU2000588Y (en) 1999-06-15 1999-06-15 Medicinal Means Deprivazini

Country Status (1)

Country Link
GE (1) GEU2000588Y (en)

Similar Documents

Publication Publication Date Title
GEP20032926B (en) Tetrahydropyridoethers
AU7735200A (en) Treatment of tissue by application of energy and drugs
FI956014A (en) Use of non- and decapeptides in the manufacture of a medicament for the treatment of AIDS
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
AU9486901A (en) Coated medical devices
AU2002232775A1 (en) Compress garment facilitating the use of medical electrodes
CA2243708A1 (en) Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection
HK1058617A1 (en) Medicinal product package for eradication therapy
AU5032500A (en) Treatment of irregular ventricular contractions
MY164077A (en) Compositions and uses of et743 for treating cancer
WO1998035658A3 (en) The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
HK1047707A1 (en) Use of (+)-tramadol, o-demethyltramadol or (+)-o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol or (+)-o-desmethyl-n-mono-desmethyl-tramadol for treating urinary incontinence
ZA981779B (en) The use of levobupivacaine in facial surgery
AU6241096A (en) A cosmetic antimycotic composition for skin applications and pharmaceutical composition for the treatment of tumorous cells, bladder or nerve disorders
GEU2000588Y (en) Medicinal Means Deprivazini
AU1898792A (en) Treatment or therapeutic booth for energetic, cosmetic and medical purposes
WO2001034174A3 (en) Methods for administration of therapeutic agents on an antiangiogenic schedule
AU2003244636A1 (en) Hair care composition
WO2000010590A3 (en) Cancer treatment
GEP20032945B (en) Medicinal Preparations
ZA977004B (en) Therapeutic product and its use
PL365040A1 (en) Use of fibrates for the preparation of a medicament useful in the treatment of congestive heart failure
AU1399100A (en) Therapeutic treatment with immunogenic drugs
AU3610999A (en) Thiocolchicoside derivative, preparation and therapeutic application
AU6819898A (en) Oxygen anion radicals and/or therapeutic preparations containing their reaction or breakdown products, and use of such preparations in the treatment of parkinson's disease